These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8064798)

  • 1. Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors.
    Scammells PJ; Baker SP; Belardinelli L; Olsson RA
    J Med Chem; 1994 Aug; 37(17):2704-12. PubMed ID: 8064798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A1 adenosine receptor antagonists as ligands for positron emission tomography (PET) and single-photon emission tomography (SPET).
    Holschbach MH; Fein T; Krummeich C; Lewis RG; Wutz W; Schwabe U; Unterlugauer D; Olsson RA
    J Med Chem; 1998 Feb; 41(4):555-63. PubMed ID: 9484505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors.
    Shimada J; Suzuki F; Nonaka H; Ishii A
    J Med Chem; 1992 Mar; 35(5):924-30. PubMed ID: 1548682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel irreversible antagonist of the A1-adenosine receptor.
    Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
    Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.
    Alexander SP; Curtis AR; Kendall DA; Hill SJ
    Br J Pharmacol; 1994 Dec; 113(4):1501-7. PubMed ID: 7889308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.
    Boring DL; Ji XD; Zimmet J; Taylor KE; Stiles GL; Jacobson KA
    Bioconjug Chem; 1991; 2(2):77-88. PubMed ID: 1868116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of domains of the human A1 adenosine receptor that are important for binding receptor subtype-selective ligands using chimeric A1/A2a adenosine receptors.
    Rivkees SA; Lasbury ME; Barbhaiya H
    J Biol Chem; 1995 Sep; 270(35):20485-90. PubMed ID: 7657625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes.
    Peakman MC; Hill SJ
    Br J Pharmacol; 1994 Jan; 111(1):191-8. PubMed ID: 8012696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor.
    Beauglehole AR; Baker SP; Scammells PJ
    J Med Chem; 2000 Dec; 43(26):4973-80. PubMed ID: 11150167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors.
    Katsushima T; Nieves L; Wells JN
    J Med Chem; 1990 Jul; 33(7):1906-10. PubMed ID: 1694546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-Azaxanthine derivatives as antagonists of adenosine receptors.
    Franchetti P; Messini L; Cappellacci L; Grifantini M; Lucacchini A; Martini C; Senatore G
    J Med Chem; 1994 Sep; 37(18):2970-5. PubMed ID: 8071944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New irreversible adenosine A(1) antagonists based on FSCPX.
    Beauglehole AR; Baker SP; Scammells PJ
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3179-82. PubMed ID: 12372528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and use of FSCPX, an irreversible adenosine A1 antagonist, as a 'receptor knock-down' tool.
    van Muijlwijk-Koezen JE; Timmerman H; van der Sluis RP; van de Stolpe AC; Menge WM; Beukers MW; van der Graaf PH; de Groote M; IJzerman AP
    Bioorg Med Chem Lett; 2001 Mar; 11(6):815-8. PubMed ID: 11277527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adenosine receptors present on the plasma membrane of chromaffin cells are of the A2b subtype.
    Casadó V; Casillas T; Mallol J; Canela EI; Lluis C; Franco R
    J Neurochem; 1992 Aug; 59(2):425-31. PubMed ID: 1629718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
    Shamim MT; Ukena D; Padgett WL; Hong O; Daly JW
    J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes.
    Bruns RF; Fergus JH; Badger EW; Bristol JA; Santay LA; Hartman JD; Hays SJ; Huang CC
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan; 335(1):59-63. PubMed ID: 3574492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists.
    Strappaghetti G; Corsano S; Barbaro R; Giannaccini G; Betti L
    Bioorg Med Chem; 2001 Mar; 9(3):575-83. PubMed ID: 11310591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of an adenosine A1 binding site in human placental membranes.
    Work C; Hutchison K; Prasad M; Bruns RF; Fox IH
    Arch Biochem Biophys; 1989 Jan; 268(1):191-202. PubMed ID: 2912375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesoionic xanthine analogues: antagonists of adenosine receptors.
    Glennon RA; Tejani-Butt SM; Padgett W; Daly JW
    J Med Chem; 1984 Oct; 27(10):1364-7. PubMed ID: 6090665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.